Tier 2 — strong
An insight into the changes in skin texture and properties following dietary intervention with a nutricosmeceutical containing a blend of collagen bioactive peptides and antioxidants
Skin Pharmacology and Physiology
2017
30(3):146–158
Bibliography
- PubMed
- PMID 28528342
- Funding
- Funding statement (verbatim): "The study was funded by MINERVA Research Labs (London, UK)."
- Competing interests
- Competing interests statement (verbatim): "The nutricosmeceutical supplement (GOLD COLLAGEN® FORTE) and placebo used in this study were provided by MINERVA Research Labs (London, UK). […] The authors certify that there is no conflict of interest regarding the material discussed in this manuscript." However, co-authors Licia Genovese and Sara Sibilla are affiliated with Minerva Research Labs — the commercial manufacturer and marketer of GOLD COLLAGEN® FORTE and the study funder. Andrea Corbo was affiliated with Master II livello Università degli Studi di Camerino at time of publication. Substantial commercial conflict of interest despite the formal declaration.
Study snapshot
| Design | Randomised, double-blind, placebo-controlled clinical trial with independent aesthetic clinic assessment |
|---|---|
| Model | Healthy adult female volunteers |
| Sample | 120 randomised (60 verum, 60 placebo) |
| Intervention | 50 mL/day of GOLD COLLAGEN® FORTE liquid nutricosmeceutical (collagen bioactive peptides plus antioxidants) versus 50 mL/day matched placebo, once daily for 90 days |
| Duration | 90 days |
| Endpoints | Skin elasticity (Young's elasticity modulus); Skin architecture (histological analysis via biopsy); Self-assessment questionnaires on skin quality |